Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review Publisher



Ejtahed HS1, 2 ; Angoorani P1 ; Soroush AR1 ; Hasaniranjbar S1 ; Siadat SD2, 3 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Shariati Hospital, 5th Floor, North Kargar Ave, Tehran, 1411413137, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran

Source: Bioscience of Microbiota# Food and Health Published:2020


Abstract

Recent evidence suggests that gut microbiota-derived metabolites affect many biological processes of the host, including appetite control and weight management. Dysbiosis of the gut microbiome in obesity influences the metabolism and excretion of gut microbiota byproducts and consequently affects the physiology of the host. Since identification of the gut microbiota-host co-metabolites is essential for clarifying the interactions between the intestinal flora and the host, we conducted this systematic review to summarize all human studies that characterized the gut microbiota-related metabolites in overweight and obese individuals. A comprehensive search of the PubMed, Web of Science, and Scopus databases yielded 2,137 articles documented up to July 2018. After screening abstracts and full texts, 12 articles that used different biosamples and methodologies of metabolic profiling and fecal microbiota analysis were included. Amino acids and byproducts of amino acids, lipids and lipid-like metabolites, bile acids derivatives, and other metabolites derived from degradation of carnitine, choline, polyphenols, and purines are among the gut microbiota-derived metabolites which showed alterations in obesity. These metabolites play an important role in metabolic complications of obesity, including insulin resistance, hyperglycemia, and dyslipidemia. The results of this study could be useful in development of therapeutic strategies with the aim of modulating gut microbiota and consequently the metabolic profile in obesity. © 2020 BMFH Press.
Other Related Docs
10. Metabolomics Prospect of Obesity and Metabolic Syndrome; a Systematic Review, Journal of Diabetes and Metabolic Disorders (2022)
15. Our Little Friends With Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)
19. Microbiota Research in Iran; Current Knowledge and Future Perspective, Journal of Diabetes and Metabolic Disorders (2021)
22. Multidimensional Perspective of Obesity; Prevention to Treatment, Journal of Diabetes and Metabolic Disorders (2021)
27. Non-Alcoholic Fatty Liver Diseases: From Role of Gut Microbiota to Microbial-Based Therapies, European Journal of Clinical Microbiology and Infectious Diseases (2020)
28. Probiotics As a New Regulator for Bone Health: A Systematic Review and Meta-Analysis, Evidence-based Complementary and Alternative Medicine (2021)
29. The Roles of Personalized Nutrition in Obesity and Diabetes Management: A Review, Journal of Diabetes and Metabolic Disorders (2022)
30. Neuromodulatory Effect of Microbiome on Gut-Brain Axis; New Target for Obesity Drugs, Journal of Diabetes and Metabolic Disorders (2019)
31. Role of Gut Microbiome in Polycystic Ovary Syndrome, Journal of Mazandaran University of Medical Sciences (2021)
32. Gut Microbiota in Nonalcoholic Fatty Liver Diseases With and Without Type-2 Diabetes Mellitus, European Journal of Gastroenterology and Hepatology (2021)
46. The Role of Intestinal Microbiota in Cognitive Disorders, Journal of Mazandaran University of Medical Sciences (2021)
47. Trimethylamine N-Oxide As a Potential Risk Factor for Non-Communicable Diseases: A Systematic Review, Endocrine# Metabolic and Immune Disorders - Drug Targets (2023)
48. Gut Microbiome and Multiple Sclerosis: New Insights and Perspective, International Immunopharmacology (2020)